InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by York Michael, Vice-Président. Insider active across 3 companies, notably PhaseBio Pharmaceuticals Inc. Aggregated, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €41k. History available since 20 May 2021. The latest transaction was filed on 26 January 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
107,054 shares@ US$0.4141100.0% of flowCommon StockSEC:0001209191-23-005275:0
210,553 shares0Common StockSEC:0001209191-22-014077:0
2,897 shares@ US$2.8050.0% of flowCommon StockSEC:0001169245-21-000044
2,897 shares@ US$2.8050.0% of flowCommon StockSEC:0001169245-21-000044:0
4 of 4 declarations
About York Michael
Michael York is the Vice President of Corporate Development and Chief Business Officer at PhaseBio Pharmaceuticals Inc and Metacrine, Inc. He plays a key role in business development strategy and activity expansion. His expertise contributes to the growth and innovation of the companies.
